Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial-Reference-Cited by-同舟云学术

Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial

Published:2017-06 Issue:10086 Volume:389 Page:2287-2303
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Blauvelt Andrew,de Bruin-Weller Marjolein,Gooderham Melinda,Cather Jennifer C,Weisman Jamie,Pariser David,Simpson Eric L,Papp Kim A,Hong H Chih-Ho,Rubel Diana,Foley Peter,Prens Errol,Griffiths Christopher E M,Etoh Takafumi,Pinto Pedro Herranz,Pujol Ramon M,Szepietowski Jacek C,Ettler Karel,Kemény Lajos,Zhu Xiaoping,Akinlade Bolanle,Hultsch Thomas,Mastey Vera,Gadkari Abhijit,Eckert Laurent,Amin Nikhil,Graham Neil M H,Pirozzi Gianluca,Stahl Neil,Yancopoulos George D,Shumel Brad

Publisher

Elsevier BV

Subject

General Medicine

Reference41 articles.

1. Atopic dermatitis;Weidinger;Lancet,2016

2. Diagnostic features of atopic dermatitis;Hanifin;Acta Dermatovener (Stockholm),1980

3. Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis;Eichenfield;J Am Acad Dermatol,2014

4. Adult eczema prevalence and associations with asthma and other health and demographic factors: a US population-based study;Silverberg;J Allergy Clin Immunol,2013

5. Addressing treatment challenges in atopic dermatitis with novel topical therapies;Silverberg;J Dermatolog Treat,2016

Cited by 865 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of dupilumab and risk factors for dupilumab-induced hypereosinophilia in severe asthma: a preliminary study from China;Annals of Medicine;2024-02-05

2. Evaluation and Management of Pruritus and Scabies in the Elderly Population;Clinics in Geriatric Medicine;2024-02

3. [Artículo traducido]Eficacia y seguridad de dupilumab para el tratamiento de la dermatitis atópica grave en la práctica clínica: experiencia en un centro terciario;Actas Dermo-Sifiliográficas;2024-02

4. Efficacy and Safety of Dupilumab for the Treatment of Severe Atopic Dermatitis in Clinical Practice: A Single Center Experience;Actas Dermo-Sifiliográficas;2024-02

5. Phase 2b randomized trial of OX40 inhibitor telazorlimab for moderate-to-severe atopic dermatitis;Journal of Allergy and Clinical Immunology: Global;2024-02